STCUBE
Develops immuno-oncology therapies targeting novel immune checkpoints for cancer.
052020 | KO
Overview
Corporate Details
- ISIN(s):
- KR7052020005
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 영동대로 511 2201(삼성동, 무역센터 트레이드타워), 강남구
- Website:
- https://www.stcube.com/en/
Description
STCube is a biopharmaceutical company specializing in the research and development of innovative immuno-oncology therapies. The company focuses on discovering treatments that target novel immune checkpoints to overcome cancer's immune evasion mechanisms. Its primary area of research involves BTN1A1, a novel immune checkpoint target often expressed in a mutually exclusive manner with PD-L1. STCube's lead drug candidate, Nelmastobart, is a first-in-class anti-BTN1A1 immune checkpoint inhibitor. This therapy is being developed to provide a new treatment option for patients with treatment-resistant, refractory, or recurrent cancers that have limited therapeutic alternatives. The company utilizes a precision-medicine, biomarker-driven approach in its clinical development programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-18 00:00 |
기업설명회(IR)개최
|
Korean | HTML • 7.2 KB | ||
| 2025-08-25 00:00 |
투자판단관련주요경영사항(임상시험계획자진취하등) (면역항암제 hSTC810 의 미국 식품의약국(FDA) 제1b/2상 임상…
|
Korean | HTML • 14.5 KB | ||
| 2025-08-25 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청) (Nelmastobart(hSTC810)의 진행성/전이성 비소세포폐암 제2…
|
Korean | HTML • 9.1 KB | ||
| 2025-08-14 00:00 |
[기재정정]사업보고서 (2024.12)
|
Korean | HTML • 1.9 MB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | HTML • 1.2 MB | ||
| 2025-06-30 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 24.3 KB | ||
| 2025-05-15 00:00 |
분기보고서 (2025.03)
|
Korean | HTML • 1.3 MB | ||
| 2025-03-20 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정) (면역항암제 Nelmastobart(hSTC810)의 전이성/재발성 …
|
Korean | HTML • 13.1 KB | ||
| 2025-03-19 00:00 |
정기주주총회결과
|
Korean | HTML • 29.9 KB | ||
| 2025-03-19 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | HTML • 10.7 KB | ||
| 2025-03-11 00:00 |
감사보고서제출
|
Korean | HTML • 25.6 KB | ||
| 2025-03-11 00:00 |
사업보고서 (2024.12)
|
Korean | HTML • 504.8 KB | ||
| 2025-03-04 00:00 |
[기재정정]의결권대리행사권유참고서류
|
Korean | HTML • 190.4 KB | ||
| 2025-02-28 00:00 |
주주총회소집공고
|
Korean | HTML • 202.3 KB | ||
| 2025-02-28 00:00 |
의결권대리행사권유참고서류
|
Korean | HTML • 186.5 KB |
Automate Your Workflow. Get a real-time feed of all STCUBE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for STCUBE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for STCUBE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
